Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:34 AM
Ignite Modification Date:
2025-12-25 @ 1:34 AM
NCT ID:
NCT00246194
Eligibility Criteria:
Inclusion Criteria:
* Patients had schizophrenia (disorganized, catatonic, paranoid, residual, or undifferentiated) that met disease diagnostic criteria as defined in Diagnostic and Statistical Manual of Mental Disorders IV (\[DSM-IV\]
* Requiring new treatment with long-acting risperidone injectable
* Patients were cooperative, reliable, and able to complete all aspects of the protocol
Exclusion Criteria:
* Use of an investigational drug in the past 30 days
* At risk to self or others
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00246194
Study Brief:
Protocol Section:
NCT00246194